Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Improving drug safety for pregnant women by delivering current and authoritative information via mobile devices

    SBC: RightAnswer.Com, Inc.            Topic: NCBDDD

    Project SummaryAbstract! An!estimated!!infants!delivered!annually!in!the!United!States!are!born!with!birth!defects!caused!by!the!use!of! medication!during!pregnancy !!Since!the!peak!prevalence!of!some!diseases !such!as!hypertension !autoimmune!disease ! and!depression !occurs!during!the!childbearing!years !it!is!not!surprising!that!medication!use!during!pregnancy!is! common !with!nine!out!of!ten!p ...

    SBIR Phase II 2018 Department of Health and Human Services
  2. Developing Species Specific Human Taeniasis Coproantigen Detection Immunoassays

    SBC: QOOLABS, INC.            Topic: ODCDC

    As the major cause of acquired epilepsy in developing countriesNeurocysticercosisNCCis the infection of the human nervous system by the larvae of the pork tapewormTaenia soliumReportable cases are seen in non endemic countries because of increasing travel and immigrationMany infected persons are unaware of their infection or the potential risks of transmission to othersIt is important to control a ...

    SBIR Phase I 2018 Department of Health and Human Services
  3. Development of a Benchtop Laboratory Platform for Amplicon Deep Sequencing

    SBC: Trace-Ability, Inc.            Topic: ODCDC

    This proposal focuses on a solution that would address the above issues by enabling a compact and completely automated closed platform that allows DNA libraries preparation from clinical samples for deep sequencing on the MiSeq Illumina systemThe resulting benefits would be process efficiency and accessibility to NGS in parts of the world where proper laboratorieshighly skilled personnelor simply ...

    SBIR Phase I 2018 Department of Health and Human Services
  4. Dried bead format one step RT PCR assay for rabies screening

    SBC: Crosslife Technologies Inc.            Topic: ODCDC

    We propose in this proposal to complete the developmentvalidation and pursuing appropriate regulatory approvals or waivers for a RABV One Step RT PCR test kit commercializationThis rabies testing kit is planned to be developed as a user friendlyrapidand specific assay with the targeting sample types including salivaeyewashesand skin biopsiesThe kits are intended to be used for rabies transmission ...

    SBIR Phase I 2018 Department of Health and Human Services
  5. Identification of Brucella canis seroreactive antigens using a pan Brucella proteome microarray

    SBC: ImmPORT Therapeutics Inc dba Antigen Discovery Inc            Topic: ODCDC

    Brucellosis is a worldwide re emerging bacterial zoonosis that can affect a range of different mammals including cattlesheepgoatsswinedogsand importantly humansEvery yearmore thanpeople worldwide are infected with virulent strains of Brucellagram negative coccobacillus from animal hostsEstimates have been made suggesting the true incidence may be much higherFour Brucella species that have animal h ...

    SBIR Phase I 2018 Department of Health and Human Services
  6. Topic 377: Bridging the Guideline Implementation Gap: Clinical Decision Support to Improve Cancer Symptom Management

    SBC: Cognitive Medical Systems, Inc.            Topic: NCI

    Advances in clinical research have yielded many evidence-based guidelines to help clinicians provide the right care for the right patient at the right time; however, studies suggest that nearly half the time, that care does not reach the patient. Clinical decision support (CDS) is an information technology-enabled method to identify missed opportunities and optimize care. This proposal seeks to sy ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  7. Topic 371: Validation and Optimization of RP-185 as Adjuvant to Exploit the Immune Response Generated by Radiation

    SBC: Riptide Bioscience, Inc.            Topic: NCI

    Radiotherapy, a key anticancer therapy, acts not only by killing cancer cells, but also by activating the body's immune system to attack the remaining cancer cells. However, the immune-stimulating effect is weakened by the tumor's capacity to reprogram immune cells, particularly macrophages, so that they instead actively promote tumor growth. RP-185 (Riptide Biosciences, Vallejo, CA),an engineered ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. Topic 375: 18F PET Tracer For Imaging PD-L1 (Moonshot)

    SBC: SIBTECH, INC.            Topic: NCI

    New therapies, designed to enhance anti-tumor immunity are based on the blockade of the checkpoint components, either PD-1 on immune cells or PD-L1 on tumor cells. This strategy, while being spectacularly successful in some patients for some cancers, fails for many other patients. The expression of PD-L1 is highly dynamic and its prevalence within tumors can vary significantly over time. The curre ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. TOPIC 363- CONNECTING CANCER CAREGIVERS TO CARE TEAMS: DIGITAL PLATFORMS TO SUPPORT INFORMAL CANCER CAREGIVING

    SBC: Medable Inc.            Topic: NCI

    TOGETHER is a mobile application on a smart software system that informal caregivers will use to develop and implement home-based care for cancer survivors. It will help alleviate the cancer caregiving burden and facilitate communication with patients' healthcare teams by centering the conversation around a care plan. The goal of this Fast-Track project is to develop and validate a final TOGETHER ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Topic 345: RadTox- Measuring Radiation Toxicity using Circulating DNA

    SBC: DiaCarta, Inc.            Topic: NCI

    The QuantiDNA RadTox System is a unique, patented technology that measures tissue damage shortly following injury using cell-free DNA from a drop of blood. Premised on murine and primate studies showing circulating DNA is logarithmically increased with whole-body radiation dose, RadTox has the potential to overcome many of the species-specific challenges faced by biomarker panels. The phase I SBIR ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government